Heated Humidified High Flow Nasal Cannula for Children With Obstructive Sleep Apnea
NCT ID: NCT02515409
Last Updated: 2015-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2015-08-31
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of High Flow Nasal Cannula Therapy to Nasal Oxygen as a Treatment for Obstructive Sleep Apnea in Infants
NCT02858154
High Flow Nasal Cannula Therapy for Childhood OSA
NCT03933800
Nasal High Flow Therapy in the Paediatric Home Setting
NCT04037839
Diaphragmatic Work During HFNC and CPAP Support
NCT06249009
Airway Pressure During Humidified High Flow Nasal Cannula Therapy in Children
NCT02387632
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CPAP
CPAP, as a first line treatment to OSAS.
CPAP
CPAP, as a first line treatment in OSAS.
HHHFNC
Treatment with HHHFNC after CPAP treatment fails.
HHHFNC
After the treatment with CPAP fails, the participants will use HHHFNC as a treatment for OSAS.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HHHFNC
After the treatment with CPAP fails, the participants will use HHHFNC as a treatment for OSAS.
CPAP
CPAP, as a first line treatment in OSAS.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Refered for treatment with non invasive ventilation.
* Diagnosed with OSAS and AHI\>=5
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tel-Aviv Sourasky Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Keren Armoni-Domany, Dr.
Role: PRINCIPAL_INVESTIGATOR
Tel-Aviv Sourasky Medical Center
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TASMC-15-KA-0263-15-TLV-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.